ArticleSurgical neurology international2026
Orbital neuromuscular hamartoma with cavernous sinus involvement: A case report of a rare trigeminal nerve tumor.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neuromuscular hamartoma (NMH), or benign triton tumor, is a uncommon peripheral nerve lesion of mature skeletal muscle fibers mixed with nerve elements. Trigeminal nerve involvement is rare, especially with combined intraorbital and intracranial extension. Case Description: A 35-year-old woman with a 6-year history of right-sided proptosis, retro-orbital pain, diplopia, and visual impairment. A prior biopsy suggested schwannoma, and radiotherapy was performed without improvement. Examination showed right cranial nerve III, IV, and VI palsies. Magnetic resonance imaging revealed a heterogeneous mass extending from the orbit through the superior orbital fissure into middle cranial fossa and cavernous sinus. The lesion was treated with a staged surgical approach with intracranial resection followed by orbital exploration with evisceration of the nonfunctional eye. Histopathology confirmed NMH. Postoperative imaging showed gross-total resection without recurrence. Conclusion: NMH of the trigeminal nerve is a uncommon entity that can mimic more aggressive neoplasms on imaging, leading to misdiagnosis. Accurate histopathological evaluation and multidisciplinary decision-making are crucial. For orbital and cavernous sinus involvement, staged surgery can provide effective disease control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.